(Q36708951)

15 August 2017

1 reference

title

Overview of the pharmacogenomics of cigarette smoking (English)

1 reference

15 August 2017

1 reference

M K Ho

1

1 reference

15 August 2017

R F Tyndale

series ordinal

2

1 reference

15 August 2017

publication date

16 January 2007

1 reference

The Pharmacogenomics Journal

15 August 2017

published in

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

81-98

1 reference

The genetics of nicotine dependence

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Pharmacotherapy for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Stages in the development of adolescent smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genetic models for the natural history of smoking: evidence for a genetic influence on smoking persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A population-based twin study in women of smoking initiation and nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genetic contribution to risk of smoking initiation: comparisons across birth cohorts and across cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The genetics of smoking persistence in men and women: a multicultural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The genetic epidemiology of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Heritability of smoking initiation and nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genetics and drug use as a complex phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The genetics of smoking initiation and quantity smoked in Dutch adolescent and young adult twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Smoking and alcohol consumption in adult male twins: genetic heritability and shared environmental influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The consumption of tobacco, alcohol, and coffee in Caucasian male twins: a multivariate genetic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Linkage analysis of smoking initiation and quantity in Dutch sibling pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Defining nicotine dependence for genetic research: evidence from Australian twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Estimating two-stage models for genetic influences on alcohol, tobacco or drug use initiation and dependence vulnerability in twin and family data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genome-wide linkage scan to identify Loci for age at first cigarette in Dutch sibling pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A possible smoking susceptibility locus on chromosome 11p12: evidence from sex-limitation linkage analyses in a sample of Australian twin families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Tobacco consumption in Swedish twins reared apart and reared together

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genetics of alcohol and tobacco use in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The genetics of tobacco use: methods, findings and policy implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Susceptibility genes for nicotine dependence: a genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A genome-wide screen for nicotine dependence susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genetic analysis of maximum cigarette-use phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A genomic scan for habitual smoking in families of alcoholics: common and specific genetic factors in substance dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Multiple genome-wide analyses of smoking behavior in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genomic screen for loci associated with tobacco usage in Mission Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Results of a genomewide linkage scan: support for chromosomes 9 and 11 loci increasing risk for cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A genome-wide scan to identify loci for smoking rate in the Framingham Heart Study population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Brain uptake kinetics of nicotine and cotinine after chronic nicotine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Presynaptic nicotinic ACh receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The effects of cholinergic and dopaminergic antagonists on nicotine-induced cerebral neurotransmitter changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Nicotine addiction: the possible role of functional upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Dramatic decreases in brain reward function during nicotine withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

D2 dopamine receptor gene and cigarette smoking: a reward gene?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Association between smoking habits and dopamine receptor D2 taqI A A2 allele in Japanese males: a confirmatory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The genetic basis for smoking behavior: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Association of the DRD4 exon III polymorphism with smoking in fifteen-year-olds: a mediating role for novelty seeking?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Polymorphisms in genes involved in neurotransmission in relation to smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

An association study of DRD5 with smoking initiation and progression to nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Association of smoking and personality with a polymorphism of the dopamine transporter gene: results from a community survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Association between polymorphism of the dopamine transporter gene and early smoking onset: an interaction risk on nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Association between dependent smoking and a polymorphism in the tyrosine hydroxylase gene in a prospective population-based study of adolescent health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Nicotine dependence in a prospective population-based study of adolescents: the protective role of a functional tyrosine hydroxylase polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers: seeking confirmation of the association in a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A functional polymorphism in the monoamine oxidase A gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Monoamine oxidase polymorphisms and smoking behaviour in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Association between monoamine oxidase gene polymorphisms and smoking behaviour in Chinese males

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Catechol-O-methyl-transferase functional polymorphism and nicotine dependence: an evaluation of nonreplicated results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Effects of systemic nicotine on serotonin release in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Effects of nicotine and mecamylamine on rat dorsal raphe neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The contribution of genetics to addiction therapy approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Serotonin transporters: implications for antidepressant drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Suicidal behavior: relationship between phenotype and serotonergic genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Association of the serotonin transporter gene with smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The serotonin transporter gene polymorphism is not associated with smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Tryptophan hydroxylase gene variant and smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Association of the tryptophan hydroxylase gene with smoking initiation but not progression to nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Pleiotropic effect of the TPH A779C polymorphism on nicotine dependence and personality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genetic and functional analysis of single nucleotide polymorphisms in the beta2-neuronal nicotinic acetylcholine receptor gene (CHRNB2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Co-morbidity of smoking in patients with psychiatric and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Nicotine use in schizophrenia: the self medication hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Schizophrenia, sensory gating, and nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A novel permutation testing method implicates sixteen nicotinic acetylcholine receptor genes as risk factors for smoking in schizophrenia families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Response of nicotine self-administration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Mu-opioid receptor and CREB activation are required for nicotine reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Anticraving medications for relapse prevention: a possible new class of psychoactive medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Nicotine and endogenous opioids: toward specific pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A potent and selective endogenous agonist for the mu-opiate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Pharmacogenetics of opioid receptors and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Drug development. Drugs inspired by a drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A missense mutation in human fatty acid amide hydrolase associated with problem drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Significant association of BDNF haplotypes in European-American male smokers but not in European-American female or African-American smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Association study between brain-derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Metabolism of nicotine to cotinine studied by a dual stable isotope method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Nicotine metabolism and CYP2A6 allele frequencies in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Nicotine metabolism defect reduces smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genetic polymorphism of CYP2A6 as one of the potential determinants of tobacco-related cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genetic variation of CYP2A6, smoking, and risk of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A meta-analytic review of the CYP2A6 genotype and smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

DAT's not all, but it may be more than we realize

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Non-replication of genetic association studies: is DAT all, folks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Pharmacogenetics and nicotine addiction treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Comment on "The public health implications of smoking-induced decreased serum and red blood cell folate levels".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Pharmacogenetic investigation of smoking cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Mapping and verification of susceptibility loci for smoking quantity using permutation linkage analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Interacting effects of genetic predisposition and depression on adolescent smoking progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A genome-wide search for loci contributing to smoking and alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

A comparison of sustained-release bupropion and placebo for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Heavy consumption of cigarettes, alcohol and coffee in male twins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Common genetic vulnerability for nicotine and alcohol dependence in men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Smoking behavior is under the influence of a major quantitative trait locus on human chromosome 5q

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

1 reference

7 January 2021

D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Organ transplants carry a rare risk of hidden cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Lack of effect of D2 dopamine receptor TaqI A polymorphism on smoking cessation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

The DRD4 VNTR polymorphism influences reactivity to smoking cues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Population genetic study of the human dopamine transporter gene (DAT1)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Evidence suggesting the role of specific genetic factors in cigarette smoking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

A genetic association for cigarette smoking behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Lack of association of tyrosine hydroxylase genetic polymorphism with cigarette smoking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

The secretory response of hypothalamic beta-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

An association of CYP2A6 genotype and smoking topography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500436

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500436

1 reference

Dimensions Publication ID

15 August 2017

1045135204

0 references

1 reference